191 related articles for article (PubMed ID: 24843139)
1. DA-Raf-dependent inhibition of the Ras-ERK signaling pathway in type 2 alveolar epithelial cells controls alveolar formation.
Watanabe-Takano H; Takano K; Sakamoto A; Matsumoto K; Tokuhisa T; Endo T; Hatano M
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):E2291-300. PubMed ID: 24843139
[TBL] [Abstract][Full Text] [Related]
2. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
3. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation.
Yokoyama T; Takano K; Yoshida A; Katada F; Sun P; Takenawa T; Andoh T; Endo T
J Cell Biol; 2007 Jun; 177(5):781-93. PubMed ID: 17535970
[TBL] [Abstract][Full Text] [Related]
4. DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor.
Kanno E; Kawasaki O; Takahashi K; Takano K; Endo T
Exp Cell Res; 2018 Jan; 362(1):111-120. PubMed ID: 29129563
[TBL] [Abstract][Full Text] [Related]
5. DA-Raf, a dominant-negative regulator of the Ras-ERK pathway, is essential for skeletal myocyte differentiation including myoblast fusion and apoptosis.
Takahashi K; Itakura E; Takano K; Endo T
Exp Cell Res; 2019 Mar; 376(2):168-180. PubMed ID: 30742807
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative antagonists of the Ras-ERK pathway: DA-Raf and its related proteins generated by alternative splicing of Raf.
Endo T
Exp Cell Res; 2020 Feb; 387(2):111775. PubMed ID: 31843497
[TBL] [Abstract][Full Text] [Related]
7. Dopamine activates ERKs in alveolar epithelial cells via Ras-PKC-dependent and Grb2/Sos-independent mechanisms.
Guerrero C; Pesce L; Lecuona E; Ridge KM; Sznajder JI
Am J Physiol Lung Cell Mol Physiol; 2002 May; 282(5):L1099-107. PubMed ID: 11943676
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
Pan MR; Chang HC; Hung WC
Cell Signal; 2008 Jun; 20(6):1134-41. PubMed ID: 18374541
[TBL] [Abstract][Full Text] [Related]
9. Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration.
Mooz J; Oberoi-Khanuja TK; Harms GS; Wang W; Jaiswal BS; Seshagiri S; Tikkanen R; Rajalingam K
Sci Signal; 2014 Aug; 7(337):ra73. PubMed ID: 25097033
[TBL] [Abstract][Full Text] [Related]
10. Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activity.
Ishii N; Harada N; Joseph EW; Ohara K; Miura T; Sakamoto H; Matsuda Y; Tomii Y; Tachibana-Kondo Y; Iikura H; Aoki T; Shimma N; Arisawa M; Sowa Y; Poulikakos PI; Rosen N; Aoki Y; Sakai T
Cancer Res; 2013 Jul; 73(13):4050-4060. PubMed ID: 23667175
[TBL] [Abstract][Full Text] [Related]
11. Cyclic stretch activates ERK1/2 via G proteins and EGFR in alveolar epithelial cells.
Correa-Meyer E; Pesce L; Guerrero C; Sznajder JI
Am J Physiol Lung Cell Mol Physiol; 2002 May; 282(5):L883-91. PubMed ID: 11943650
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of Ras/Raf oncogenes and the MEK1/ERK signaling module in regulation of expression and adhesive function of surface transglutaminase.
Akimov SS; Belkin AM
J Biol Chem; 2003 Sep; 278(37):35609-19. PubMed ID: 12832399
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-10 attenuates H2O2-induced alveolar epithelial cell DNA damage: role of MAPK activation and DNA repair.
Upadhyay D; Bundesmann M; Panduri V; Correa-Meyer E; Kamp DW
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):107-13. PubMed ID: 14975937
[TBL] [Abstract][Full Text] [Related]
15. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
[TBL] [Abstract][Full Text] [Related]
16. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
17. Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth.
Zanucco E; El-Nikhely N; Götz R; Weidmann K; Pfeiffer V; Savai R; Seeger W; Ullrich A; Rapp UR
J Biol Chem; 2014 Sep; 289(39):26804-26816. PubMed ID: 25096573
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human keratinocyte growth factor in inducing Ras-Raf-Erk pathway-mediated cell proliferation in emphysematous mice lung.
Muyal JP; Kotnala S; Bhardwaj H; Tyagi A
Inhal Toxicol; 2014 Nov; 26(13):761-71. PubMed ID: 25296878
[TBL] [Abstract][Full Text] [Related]
19. Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development.
Galabova-Kovacs G; Catalanotti F; Matzen D; Reyes GX; Zezula J; Herbst R; Silva A; Walter I; Baccarini M
J Cell Biol; 2008 Mar; 180(5):947-55. PubMed ID: 18332218
[TBL] [Abstract][Full Text] [Related]
20. Raf: a strategic target for therapeutic development against cancer.
Beeram M; Patnaik A; Rowinsky EK
J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
